TEVA   $17.865  -0.03% Market Open

Teva Pharmaceutical Industries Ltd
Total Cash 2.26B
totalCashPerShare 1.993
EBITDA 4.57B
Total Debt 18.92B
quickRatio 0.462
currentRatio 0.892
Total Revenue 16.29B
debtToEquity 288.313
Revenue/Share 14.493
ROA 0.05159
ROE -0.10511
grossProfits
freeCashflow 3.37B
operatingCashflow 1.17B
earningsGrowth
revenueGrowth 0.074
grossMargins 0.49497002
ebitdaMargins 0.28023002
operatingMargins 0.19621
profitMargins -0.02781
enterpriseValue 37.72B
forwardPE 6.6462092
floatShares 1.13B
sharesOutstanding 1.13B
sharesShort 23.95M
sharesShortPriorMonth 19.50M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.55%
Short Ratio help_outline 2.66%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 5.613
Price To Book help_outline 3.28
earningsQuarterlyGrowth
netIncomeToCommon -453.00M
trailingEps -0.39%
forwardEps 2.77%
enterpriseToEbitda 8.26
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.66 3Q 2024
institutionsCount 723
lastUpdated Sept. 16, 2024, 12:19 p.m.